Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, et al. Cancer Res 2022 Oct 7. pii: 709668. doi: 10.1158/0008-5472.CAN-22-0455.

Read + Share

Amedeo Smart

Independent Medical Education

Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, et al. Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Cancer Res 2022 Oct 7. pii: 709668. doi: 10.1158/0008-5472.CAN-22-0455.
PMID: 36206317